Calculating AUC (Linear and Log-linear) Blog Post
AUC 计算简单，但也有细微差别。In this blog, we look at how to calculate AUC with non-compartmental analysis techniques.
Accumulation: What It Means and How to Calculate It Blog Post
Ana Henry Register for our July 10 webinar and discover fast, flexible, frictionless PK/PD workflows with Phoenix Cloud. 2025 年 4 月 2 日 In this blog, we look closely at drug accumulation... Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities Blog Post
RADNOR, PA — April 1st, 2025 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development, has released a new version of the Simcyp™ Simulator for physiologically-based pharmacokinetic (PBPK) modeling.
How to Make 3rd Party Reconciliation in Clinical Data Management More Efficient Blog Post
Learn how to streamline 3rd party reconciliation in clinical data management with reusable standards, centralized communication & in-stream data validation.
MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants Blog Post
[event_date_range]
Building effective health economic models: key components for success Blog Post
Mohsen Yaghoubi Kinga Pacocha 2025 年 3 月 28 日 Editor’s note: This is the first in a series of four articles on the crucial role health economic modeling plays in evaluating the...
Mechanistic Modeling Guides Bispecific Antibody Design and Target Selection for Maximizing Therapeutic Window Blog Post
Download PDF Learn more about Assess™ QSP Software for Early Feasibility Assessment Assess™ is a revolutionary QSP modeling software that empowers researchers to make evidence-based decisions earlier in the drug...
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy? Blog Post
Certara’s Steve Sibley, Vice President Regulatory Strategy, is quoted in this Pharma's Almanac article about the challenges of balancing faster drug approvals with patient safety and efficacy. 阅读文章... 
